The International Conference on Synthetic Biology hosted by Meetings International was held in Paris, France this July for leaders within the Synthetic Biology field to gather and discuss the latest developments with upcoming technologies.
Bruce Dannenberg, President and CEO of Phytonix, accepted an invitation and made a keynote presentation on the current and upcoming advancements in the technologies of Phytonix Corporation.
To learn more about this conference click the link below.
President and CEO of Phytonix Corporation, Bruce Dannenberg, accepted an invitation to chair and present at the CO2 Reuse Summit hosted by Cogiton Group this past May in Zurich, Switzerland. This conference is dedicated to building the industry of Carbon Dioxide Utilization in order to move towards a decarbonized future.
Mr. Dannenberg made a presentation entitled “Biological Carbon Dioxide Utilization Technology for the Production of Low Cost Industrial Chemicals Utilizing Photosynthesis” in addition to chairing both days of the conference.
To learn more about additional speakers and sponsors of this conference follow the link below.
ACI’s 10th Carbon Dioxide Utilization Summit follows on from a successful series of conferences focusing on the re-use of greenhouse gas CO2 and converting this into profitable sustainable materials. The two day conference brings together senior experts from various CO2 emitting industries discussing the sustainable, technological and commercial aspects of CO2 Utilization in North America and across the globe.
Mr. Bruce Dannenberg, Founder and CEO of Phytonix Corporation, has chaired and presented at this conference four consecutive years.
As Summit Chairman, Mr. Dannenberg provided opening and closing remarks each day, led meaningful discussions about the future of Carbon Dioxide Utilization, and presented current and upcoming Phytonix advancements.
For further details please visit: http://www.wplgroup.com/aci/event/co2-us/
Mr. Bruce Dannenberg, President and CEO of Phytonix Corporation, accepted an invitation to participate in and present at the one-day information-gathering meeting organized by The National Academies of Sciences, Engineering, and Medicine to answer the questions “What will the likely future products of biotechnology be over the next 5-10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?”
Mr. Dannenberg provided the committee with important and valuable insights in regards to Phytonix’s breakthrough technology and it’s leadership approach for the utilization of both passive and active (proprietary) strategies and technology for the bio-safety guarded photobiological production of sustainable chemicals. This could provide a framework for future self-regulatory approaches and how these types of approaches might relate to appropriate future levels of mandated regulations.
To view Mr. Dannenberg’s presentation click the link below.
Click on the link below to view the 05/12/2014 feature newspaper article on Phytonix and It’s founder, Bruce Dannenberg:
Phytonix’s technology integrates 21st century scientific ingenuity with the ancient and elegant process of photosynthesis. We believe that this combination holds great potential to provide for civilizations’ future industrial chemical needs while alleviating the stress on Earth’s environment for the betterment of all life that it supports.
Source: Pacific Northwest National Lab
Phytonix has an international patent and patent-pending IP portfolio for bio-safe renewable chemicals production.
Continue reading “Our IP Portfolio”
Phytonix’s proprietary technology will produce bio-butanol and bio-octanol from photosynthetic bacteria, carbon dioxide, sunlight, and water.
Continue reading “Our Technology”
Phytonix is targeting the $50 billion global industrial chemical market for higher alcohols (four to eight carbon alcohols and their isomers).
Continue reading “Target Market”